Skip to content

Clinical trials

Phase 2 Neoplasms trials in South Korea

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neoplasms Phase: Phase 2 Country / region: South Korea Clear all

75 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20071
20083
20092
20106
20113
20123
20132
20146
20153
20162
20188
20197
20204
20213
20224
20236
20242
20257
20263

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Terminated13
Recruiting12
Active, not recruiting10
Unknown status10
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AbbVie7
Novartis Pharmaceuticals7
Asan Medical Center6
GlaxoSmithKline6
Pfizer5
Merck Sharp & Dohme LLC4
Samsung Medical Center4
AstraZeneca2
CytomX Therapeutics2
Janssen Research & Development, LLC2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neoplasms75
Carcinoma, Non-Small-Cell Lung13
Neoplasm Metastasis9
Colorectal Neoplasms5
Lung Neoplasms5
Stomach Neoplasms5
Biliary Tract Neoplasms4
Breast Neoplasms4
Melanoma4
Leukemia3

Trials

Showing 1 to 25 of 75. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.